© 1996 American Heart Association, Inc.
Articles |
The Fumagillin Analogue TNP-470 Inhibits DNA Synthesis of Vascular Smooth Muscle Cells Stimulated by Platelet-Derived Growth Factor and Insulin-like Growth Factor-I
Possible Involvement of Cyclin-Dependent Kinase 2
the Second Department of Internal Medicine, Osaka (Japan) City University Medical School.
Correspondence to Yoshiki Nishizawa, MD, Second Department of Internal Medicine, Osaka City University Medical School, 1-5-7, Asahi-machi, Abeno-ku, Osaka 545, Japan.
The effect of an angiogenesis inhibitor, TNP-470, on DNA synthesis and its underlying signaling cascades stimulated by platelet-derived growth factor (PDGF)-BB and insulin-like growth factor (IGF)-I were examined in bovine vascular smooth muscle cells (SMCs). PDGF-BB (10 ng/mL)– and IGF-I (100 ng/mL)–stimulated increase in DNA synthesis was completely abolished by simultaneous treatment with TNP-470 (1.0 ng/mL). TNP-470 had no effects on PDGF receptor autophosphorylation or early signal transduction, such as activation of mitogen-activated protein kinase and immediate early gene expression. PDGF-BB induced an increase in mRNA levels of cyclin D1, cyclin-dependent kinase (cdk) 4, and cdk2, as well as the activity of cdk2, which preceded the G1/S boundary, as estimated by the kinetics of DNA synthesis. The PDGF-BB–induced activation of cdk2 was inhibited by TNP-470, which was correlated with decreased cdk2 mRNA levels. In contrast, TNP-470 had no or less marked effect on cyclin D1 and cdk4 mRNA levels induced by PDGF-BB. TNP-470 also inhibited a much smaller increase in cdk2 mRNA levels and activation stimulated by IGF-I. In conclusion, TNP-470 potently inhibits DNA synthesis of SMCs, and this inhibition is associated with decreased levels of cdk2 mRNA and activity.
Key Words: TNP-470 • bovine vascular smooth muscle cells • platelet-derived growth factor • insulin-like growth factor-I • cyclin-dependent kinase 2
This article has been cited by other articles:
 |
|
 |
|
  R. H. Alvarez, H. M. Kantarjian, and J. E. Cortes Biology of Platelet-Derived Growth Factor and Its Involvement in Disease Mayo Clin. Proc., September 1, 2006; 81(9): 1241 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, J. S. Frischer, T. New, E. S. Kim, A. Serur, A. Lee, A. Kadenhe-Chiwishe, D. A. Pollyea, A. Yokoi, J. Holash, et al. TNP-470 promotes initial vascular sprouting in xenograft tumors Mol. Cancer Ther., March 1, 2004; 3(3): 335 - 343. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Ichii, H. Koyama, S. Tanaka, S. Kim, A. Shioi, Y. Okuno, E. W. Raines, H. Iwao, S. Otani, and Y. Nishizawa Fibrillar Collagen Specifically Regulates Human Vascular Smooth Muscle Cell Genes Involved in Cellular Responses and the Pericellular Matrix Environment Circ. Res., March 16, 2001; 88(5): 460 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-D. C. Beecken, A. Fernandez, A. M. Joussen, E.-G. Achilles, E. Flynn, K.-M. Lo, S. D. Gillies, K. Javaherian, J. Folkman, and Y. Shing Effect of Antiangiogenic Therapy on Slowly Growing, Poorly Vascularized Tumors in Mice J Natl Cancer Inst, March 7, 2001; 93(5): 382 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, E. C. Griffith, J. Sage, T. Jacks, and J. O. Liu Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1 PNAS, June 6, 2000; 97(12): 6427 - 6432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duan, M. B. Liimatta, and O. L. Bottum Insulin-like Growth Factor (IGF)-I Regulates IGF-binding Protein-5 Gene Expression through the Phosphatidylinositol 3-Kinase, Protein Kinase B/Akt, and p70 S6 Kinase Signaling Pathway J. Biol. Chem., December 24, 1999; 274(52): 37147 - 37153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fukumoto, H. Koyama, M. Hosoi, K. Yamakawa, S. Tanaka, H. Morii, and Y. Nishizawa Distinct Role of cAMP and cGMP in the Cell Cycle Control of Vascular Smooth Muscle Cells : cGMP Delays Cell Cycle Transition Through Suppression of Cyclin D1 and Cyclin-Dependent Kinase 4 Activation Circ. Res., November 26, 1999; 85(11): 985 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yano, J. R. Bauchat, M. B. Liimatta, D. R. Clemmons, and C. Duan Down-Regulation of Protein Kinase C Inhibits Insulin-Like Growth Factor I-Induced Vascular Smooth Muscle Cell Proliferation, Migration, and Gene Expression Endocrinology, October 1, 1999; 140(10): 4622 - 4632. [Abstract] [Full Text]
|
|
|
|
 |
|
 C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Walter and D. C. Sane Angiostatin Binds to Smooth Muscle Cells in the Coronary Artery and Inhibits Smooth Muscle Cell Proliferation and Migration In Vitro Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2041 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Moulton, E. Heller, M. A. Konerding, E. Flynn, W. Palinski, and J. Folkman Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice Circulation, April 6, 1999; 99(13): 1726 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Li and G. Brooks Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? Eur. Heart J., March 2, 1999; 20(6): 406 - 420. [PDF]
|
|
|
|
 |
|
 K. M. Hawker, P. R. A. Johnson, J. M. Hughes, and J. L. Black Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L469 - L477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fukumoto, Y. Nishizawa, M. Hosoi, H. Koyama, K. Yamakawa, S. Ohno, and H. Morii Protein Kinase C delta Inhibits the Proliferation of Vascular Smooth Muscle Cells by Suppressing G1 Cyclin Expression J. Biol. Chem., May 23, 1997; 272(21): 13816 - 13822. [Abstract] [Full Text] [PDF]
|
|